The predictive value of blood neutrophil-lymphocyte ratio in patients with end-stage liver cirrhosis following ABO-incompatible liver transplantation
暂无分享,去创建一个
Lin Zhou | Shusen Zheng | L. Geng | Jun-Jun Jia | Bingyi Lin | Tian Shen | Zhi-yun Zheng | Jing Zhang
[1] L. A. Szutan,et al. Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients , 2015, Clinics.
[2] Zhengwen Liu,et al. Prognostic role of neutrophil‐to‐lymphocyte ratio in colorectal cancer: A systematic review and meta‐analysis , 2014, International journal of cancer.
[3] G. Mody,et al. Acute presentation of thrombocytopaenia in systemic lupus erythematosus is associated with a high mortality in South Africa , 2014, Lupus.
[4] D. Altshuler,et al. Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantation , 2014, Hepatology.
[5] M. Abouljoud,et al. Peritransplant Lymphopenia Is a Novel Prognostic Factor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation , 2013, Transplantation.
[6] H. Kanemoto,et al. Elevated Preoperative Neutrophil-to-lymphocyte Ratio as a Predictor of Survival After Gastroenterostomy in Patients with Advanced Pancreatic Adenocarcinoma , 2013, Annals of Surgical Oncology.
[7] Y. Beyazit,et al. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. , 2012, Clinics and research in hepatology and gastroenterology.
[8] S. Yagi,et al. Splenectomy Does Not Offer Immunological Benefits in ABO-Incompatible Liver Transplantation With a Preoperative Rituximab , 2012, Transplantation.
[9] Guihua Chen,et al. A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation , 2011, PloS one.
[10] R. Golfieri,et al. Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers , 2011, Transplantation.
[11] Y. Maehara,et al. Rituximab, IVIG, and Plasma Exchange Without Graft Local Infusion Treatment: A New Protocol in ABO Incompatible Living Donor Liver Transplantation , 2009, Transplantation.
[12] H. Ohdan,et al. Current status of liver transplantation across ABO blood-type barrier. , 2008, Journal of hepato-biliary-pancreatic surgery.
[13] Y. Maehara,et al. Successful ABO incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin. , 2007, Transplantation proceedings.
[14] M. Tanabe,et al. Present status of ABO‐incompatible living donor liver transplantation in Japan , 2007, Hepatology.
[15] François Vincent,et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. , 2007, Chest.
[16] L. Morelli,et al. Treatment of antibody‐mediated rejection with high‐dose immunoglobulins in ABO‐incompatible liver transplant recipient , 2007, Transplant international : official journal of the European Society for Organ Transplantation.
[17] P. Hellberg,et al. Neutrophil-mediated post-ischemic tubular leakage in the rat kidney. , 1989, Kidney international.
[18] I. Liou. Management of end-stage liver disease. , 2014, The Medical clinics of North America.
[19] V. Arroyo,et al. Compensated cirrhosis: Natural history and prognostic factors , 1987, Hepatology.